Author Details

Gwilt, Mike, GT Communications, Shrewsbury, UK

  • Vol 16, No 2 (2016) - Meeting Reports
    This house believes that sulphonylureas should not be used routinely as second-line treatments for patients with type 2 diabetes
    Details  HTML  PDF